share_log

HC Wainwright & Co. Reiterates Buy on Acer Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. Reiterates Buy on Acer Therapeutics, Maintains $12 Price Target

HC Wainwright & Co.重申买入宏碁 Therapeutics,维持12美元的目标股价
Benzinga ·  2023/03/28 10:48

HC Wainwright & Co. analyst Vernon Bernardino reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $12 price target.

HC Wainwright & Co. 分析师弗农·贝纳迪诺重申宏碁疗法(纳斯达克股票代码:ACER)的买入,并维持12美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发